Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway.

Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLC /PKC Signaling Pathway KRAS mutation G12C, inhibitor 9, castration-resistant prostate cancer, drug resistance, metastasis Keywords: KRAS mutation G12C; inhibitor 9; castration-resistant prostate cancer; drug resistance; metastasis EN KRAS mutation G12C inhibitor 9 castration-resistant prostate cancer drug resistance metastasis 1 1 1 06/05/21 20210531 NES 210531 Please find the retraction statement below: Following publication, concerns were raised regarding image manipulation and duplication. [Extracted from the article]